Stock Taper 
OrthoPediatrics Corp. develops and markets pediatric orthopedic implants and devices globally, including trauma, deformity correction, scoliosis, and sports medicine products for children.
This pediatric plate and screw system for proximal femur fractures and deformities is the company's first in their 'Pediatric Plating Platform' and one of their largest Trauma and Deformity division product launches.
OrthoPediatrics Corp. announced preliminary record net revenue of $236.1 million for the full year 2025, a 15% increase over the previous year. This news, released on January 12, 2026, was coupled with strong guidance for 2026 and resulted in a nearly 10% single-day surge in the company's stock price, putting it firmly in the investor spotlight.
OrthoPediatrics undertook a significant global restructuring plan in 2025, a continuation of an initiative started in the fourth quarter of 2024. This strategic shift was aimed at improving operational efficiency, reducing operating costs, and included staffing reductions to better align the company's cost structure with its long-term profitability targets.
WARSAW, Ind., Oct. 07, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) portfolio with a new product launch, the OPSB® Knee 'TractorFIX contracture management orthosis.
Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets, and h
Milestone program with record attendance brought together 39 participants from 23 institutions across 22 cities and three countries Milestone program with record attendance brought together 39 participants from 23 institutions across 22 cities and three countries
Overall rating: C-
| PEER | PRICE | |
|---|---|---|
 CBLL | $24.56 | COMPARE |
 BVS | $13.28 | COMPARE |
 EOLS | $7.39 | COMPARE |
 LAB | $0.73 | COMPARE |
 TMCI | $4.17 | COMPARE |
 RXST | $4.65 | COMPARE |
